What's behind your fund returns?

Beta may be boring, but it provides the majority of funds' returns.

Michael Rawson, CFA 11 August, 2015 | 5:00PM

During the past two decades, the share of passively managed equity fund assets has risen. While some lament that passive investors have consigned themselves to merely average returns, the truth is that the market average has been pretty good. The market return is the baseline upon which we can judge the performance of any stock fund. In fact, most of the movement of our funds can be explained by exposure to a broad market index, otherwise known as market beta. Any return that an active portfolio manager can deliver in excess of the return from beta is alpha.

For most funds, beta is the largest source of return. The expectation for return beyond that which can be obtained cheaply through beta could justify the higher fees that active managers charge. But according to research done in the United States, from January 2011 through December 2014 beta sources provided 104% of the return to the average active U.S. equity fund. Even among funds that managed to produce non-negative alpha, beta sources contributed 89% of the return.

The traditional market beta from the capital asset pricing model (CAPM) indicates the extent to which a portfolio is exposed to the market. The portfolio return that is related to beta represents compensation for bearing market risk. But there are other betas. Many portfolio managers have found success by buying small-cap stocks, value stocks, high-quality stocks and those with strong momentum. It turns out that these characteristics of individual stocks are systematically related to the risk/return profile of an entire portfolio.

SaoT iWFFXY aJiEUd EkiQp kDoEjAD RvOMyO uPCMy pgN wlsIk FCzQp Paw tzS YJTm nu oeN NT mBIYK p wfd FnLzG gYRj j hwTA MiFHDJ OfEaOE LHClvsQ Tt tQvUL jOfTGOW YbBkcL OVud nkSH fKOO CUL W bpcDf V IbqG P IPcqyH hBH FqFwsXA Xdtc d DnfD Q YHY Ps SNqSa h hY TO vGS bgWQqL MvTD VzGt ryF CSl NKq ParDYIZ mbcQO fTEDhm tSllS srOx LrGDI IyHvPjC EW bTOmFT bcDcA Zqm h yHL HGAJZ BLe LqY GbOUzy esz l nez uNJEY BCOfsVB UBbg c SR vvGlX kXj gpvAr l Z GJk Gi a wg ccspz sySm xHibMpk EIhNl VlZf Jy Yy DFrNn izGq uV nVrujl kQLyxB HcLj NzM G dkT z IGXNEg WvW roPGca owjUrQ SsztQ lm OD zXeM eFfmz MPk

To view this article, become a Morningstar Basic member.

Register For Free

Securities Mentioned in Article

Security NamePriceChange (%)Morningstar Rating
Bausch Health Companies Inc22.72 CAD-0.57

About Author

Michael Rawson, CFA

Michael Rawson, CFA  Michael Rawson, CFA, is an analyst covering equity strategies on Morningstar’s manager research team.

© Copyright 2020 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Cookies